cPLA2 is phosphorylated and activated by MAP kinase
| dc.contributor.author | Lin, Lih-Ling | |
| dc.contributor.author | Wartmann, Markus | |
| dc.contributor.author | Lin, Alice Y. | |
| dc.contributor.author | Knop, John L. | |
| dc.contributor.author | Seth, Alpna | |
| dc.contributor.author | Davis, Roger J. | |
| dc.date | 2022-08-11T08:09:01.000 | |
| dc.date.accessioned | 2022-08-23T16:15:29Z | |
| dc.date.available | 2022-08-23T16:15:29Z | |
| dc.date.issued | 1993-01-29 | |
| dc.date.submitted | 2008-11-05 | |
| dc.identifier.citation | Cell. 1993 Jan 29;72(2):269-78. | |
| dc.identifier.issn | 0092-8674 (Print) | |
| dc.identifier.pmid | 8381049 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/34099 | |
| dc.description.abstract | Treatment of cells with agents that stimulate the release of arachidonic acid causes increased serine phosphorylation and activation of cytosolic phospholipase A2 (cPLA2). Here we report that cPLA2 is a substrate for mitogen-activated protein (MAP) kinase. Moreover, phosphorylation by MAP kinase increases the enzymatic activity of cPLA2. The site of cPLA2 phosphorylation by MAP kinase, Ser-505, is identical to the major site of cPLA2 phosphorylation observed in phorbol ester-treated cells. Replacement of Ser-505 with Ala resulted in a mutant cPLA2 that is not a substrate for MAP kinase and causes little or no enhanced agonist-stimulated arachidonate release from intact cells. Taken together, these data indicate that MAP kinase mediates, at least in part, the agonist-induced activation of cPLA2. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8381049&dopt=Abstract">Link to article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1016/0092-8674(93)90666-E | |
| dc.subject | Amino Acid Sequence; Animals; CHO Cells; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cricetinae; Cytosol; Enzyme Activation; Kinetics; Models, Biological; Mutagenesis, Site-Directed; Peptide Mapping; Phospholipases A; Phospholipases A2; Phosphopeptides; Phosphorylation; Protein Kinase C; Protein Kinases; Receptors, Platelet-Derived Growth Factor; Recombinant Proteins; Serine; Tetradecanoylphorbol Acetate; Transfection | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | cPLA2 is phosphorylated and activated by MAP kinase | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Cell | |
| dc.source.volume | 72 | |
| dc.source.issue | 2 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/763 | |
| dc.identifier.contextkey | 661872 | |
| html.description.abstract | <p>Treatment of cells with agents that stimulate the release of arachidonic acid causes increased serine phosphorylation and activation of cytosolic phospholipase A2 (cPLA2). Here we report that cPLA2 is a substrate for mitogen-activated protein (MAP) kinase. Moreover, phosphorylation by MAP kinase increases the enzymatic activity of cPLA2. The site of cPLA2 phosphorylation by MAP kinase, Ser-505, is identical to the major site of cPLA2 phosphorylation observed in phorbol ester-treated cells. Replacement of Ser-505 with Ala resulted in a mutant cPLA2 that is not a substrate for MAP kinase and causes little or no enhanced agonist-stimulated arachidonate release from intact cells. Taken together, these data indicate that MAP kinase mediates, at least in part, the agonist-induced activation of cPLA2.</p> | |
| dc.identifier.submissionpath | gsbs_sp/763 | |
| dc.contributor.department | Program in Molecular Medicine | |
| dc.contributor.department | Howard Hughes Medical Institute Department of Biochemistry and Molecular Biology | |
| dc.contributor.department | Graduate School of Biomedical Sciences | |
| dc.source.pages | 269-78 |